II. Pathophysiology
- African Trypanosomiasis (African Sleeping Sickness)
- Disease affecting both humans and animals in Central Africa where it is endemic
- Caused by 2 Trypanosoma species
- T. gambiense (West African Sleeping Sickness)
- Slowly progressive fevers and wasting
- Late neurologic findings
- T. rhodesiense (East African Sleeping Sickness)
- More severe than T. gambiense (West African)
- Rapid progression from fever to neurologic symptoms to death within weeks to months
- Most disease in travelers occurs in Tanzania, Malawi or Zambia
- T. gambiense (West African Sleeping Sickness)
- Infection
- Transmitted by the bite of a blood-sucking Tsetse Fly
- Firm, red, painful Skin Ulcer forms at bite site and then heals within 2 weeks
- Trypomastigote spreads within the human bloodstream
- Trypomastigote is the motile, flagellated form of Trypanosoma
- Trypomastigote targets Lymph Nodes and the Central Nervous System
- Transmitted by the bite of a blood-sucking Tsetse Fly
- Variable Surface Glycoproteins (VSG) and undulating fever
- Trypanosomes are coated with millions of copies of a single Glycoprotein variety (VSG)
- Trypanosomes have genetic code to generate thousands of different VSGs
- However, each trypanosome surface contains only 1 VSG type at a time
- Antibody formation to a VSG triggers a strong immune response with fever
- Targeted trypanosomes generate offspring with a new VSG, not yet recognized by the host
- Ultimately Antibody is generated in 2-3 weeks, triggering an immune response and fever recurrence
- Trypanosomes are coated with millions of copies of a single Glycoprotein variety (VSG)
III. Findings
- Acute Infection
- Initial skin lesion at bite site (Week 0-2 after Tsetse bite)
- Firm, red, painful Skin Ulcer forms at bite site and then heals within 2 weeks
- Initial systemic symptoms (Week 2-3 after Tsetse bite)
- Initial skin lesion at bite site (Week 0-2 after Tsetse bite)
- Stage 1: Hemolymphatic Stage (Undulating fever months after Tsetse bite)
- Fever-free periods alternating with episodes of fever
- Stage 2: Meningoencephalitic Stage (progressive neurologic findings)
- Daytime Somnolence
- Behavior changes
- Progressive deficits in speech and walking
- Progression to coma and death
IV. Diagnosis
- Microscopy
- Trypomastigotes may be seen in peripheral blood, lymph biopsy or spinal fluid
-
Serology
- Only available for T. gambiense
V. Management: West African Trypanosomiasis (T. gambiense)
-
General
- Inpatient Antibiotic course despite oral administration
- Monitor for relapse with reevaluation (history and exam) every 6 months for 24 months
- Fexindazole
- Indications
- Age >=6 years AND body weight >20kg AND CSF Leukocytes <100 wbc/uL
- Contraindications
- First trimester pregnancy (may use in second or third trimester)
- Unknown CSF Leukocyte count OR CSF Leukocytes >100 wbc/uL
- Dosing weight >=35 kg
- Load: 1800 mg (3 tablets) once daily for 4 days
- Next: 1200 mg (2 tablets) once daily for 6 days
- Dosing weight 20 kg to 35 kg
- Load: 1200 mg (2 tablets) once daily for 4 days
- Next: 600 mg (1 tablet) once daily for 6 days
- Indications
-
NECT (Eflornithine/Nifurtimox)
- Indications
- Severe Stage 2 Trypanosomiasis with CSF Leukocytes >100 wbc/uL (any age)
- Dosing
- Eflornithine 400 mg/kg/day IV divided every 12 hours for 7 days AND
- Nifurtimox 15 mg/kg/day divided every 8 hours for 10 days
- Indications
-
Pentamidine
- Indications
- Stage 1 AND (Age <6 years OR body weight <20kg) OR
- Alternative regimen for age>=6 years and non-severe Stage 1-2 with CSF Leukocytes <100 wbc/uL
- Contraindications (use NECT instead)
- Stage 2 Trypanosomiasis AND (Age <6 years OR body weight <20kg)
- Dosing
- Pentamidine 4 mg/kg IV for 7 days
- Indications
VI. Management: East African Trypanosomiasis (T. rhodesiense)
- Fexindazole
- Indications
- Age >=6 years AND body weight >20kg (Stage 1 or 2)
- Contraindications
- Unknown CSF Leukocyte count OR CSF Leukocytes >100 wbc/uL
- First trimester pregnancy (may use in second or third trimester)
- Relative contraindication due to rapid lethality of East African Trypanosomiasis
- Start with either Fexindazole or Pentamidine in pregnancy regardless of trimester
- Dosing weight >=35 kg
- Load: 1800 mg (3 tablets) once daily for 4 days
- Next: 1200 mg (2 tablets) once daily for 6 days
- Dosing weight 20 kg to 35 kg
- Load: 1200 mg (2 tablets) once daily for 4 days
- Next: 600 mg (1 tablet) once daily for 6 days
- Indications
-
Suramin
- Indications
- Stage 1 AND (Age <6 years OR body weight >20kg)
- Dosing
- First Test Dose: 5 mg/kg IV
- Next: 20 mg/kg (up to 1 g) on days 1, 3, 7, 14 and 21
- Indications
-
Melarsoprol
- Indications
- Stage 2 AND (Age <6 years OR body weight >20kg)
- Dosing
- Melarsoprol 2.2 mg/kg/day IV for 10 days
- Consider Corticosteroid pretreatment to prevent encephalopathy
- Consider pretreatment with Suramin to treat blood stages before Melarsoprol
- Indications
VII. Resources
- African Trypanosomiasis (WHO)
- African Trypanosomiasis (Stat Pearls)
VIII. References
- Gladwin, Trattler and Mahan (2014) Clinical Microbiology, Medmaster, Fl, p. 349
- (2025) Sanford Guide, accessed 7/11/2025 on IOS
- Ortiz-MartÃnez (2023) Curr Trop Med Rep 10(4):222-34 +PMID: 38939748 [PubMed]